This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
03/31/15 - 9:30:05 AM ET (BATS BZX Real-time Price)
Div Yield: --
RGLS Day's Range
RGLS 52 Week Range
RGLS Business Summary
Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States.View RGLS key stats
Regulus Therapeutics Inc - RGLS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Regulus Therapeutics Inc as a
Sell with a ratings score of D+.
Report Snippet: We rate Regulus Therapeutics Inc (RGLS) a Sell.
This is based on the convergence of positive investment measures, which should help this stock outperform the majority
of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance,
growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company
may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.